Becton Dickinson & Co. (NYSE:BDX) said this week that its second-generation BD Nano pen needle won 510(k) clearance from the FDA.
The company’s needles are designed to provide a more reliable subcutaneous injection depth, according to BD.
Get the full story at our sister site, Drug Delivery Business News.
The post BD launches second-gen ergonomic injection pen appeared first on MassDevice.